Published in Immunotherapy Weekly, April 6th, 2005
"Upon SCF stimulation," wrote S. Zeng and coworkers at Columbia University, "KIT binds to and induces the phosphorylation of Cbl proteins, which in turn act as E3 ligases, mediating the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.